Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ehsan Hajjar

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Biotechnology|October 1, 2015
Development of Personalized Molecular Therapy for Acute Myeloid LeukemiaCaroline B N Engen, Ehsan Hajjar, Bjørn T Gjertsen
European Journal of Immunology|February 16, 2025
MAPK and STAT3 Inhibitors Modulate FoxP3 Expression and Regulatory T Cell FunctionNuria García-Díaz, Elise Solli, Ehsan Hajjar, et al.
ACS Chemical Biology|April 3, 2026
High-Throughput Phenotypic Screen to Identify FoxP3 Regulators in Primary T CellsQian Wei, Ehsan Hajjar, Selma Cornillot-Clément, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Biotechnology|October 1, 2015
Development of Personalized Molecular Therapy for Acute Myeloid LeukemiaCaroline B N Engen, Ehsan Hajjar, Bjørn T Gjertsen
European Journal of Immunology|February 16, 2025
MAPK and STAT3 Inhibitors Modulate FoxP3 Expression and Regulatory T Cell FunctionNuria García-Díaz, Elise Solli, Ehsan Hajjar, et al.
ACS Chemical Biology|April 3, 2026
High-Throughput Phenotypic Screen to Identify FoxP3 Regulators in Primary T CellsQian Wei, Ehsan Hajjar, Selma Cornillot-Clément, et al.
Pageof 1